These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2128649)

  • 1. Serotype and serum sensitivity of Pseudomonas aeruginosa from children with cystic fibrosis: longitudinal studies and typing with monoclonal antibodies.
    Burke V; Richardson CJ; Robinson J
    Pathology; 1990 Oct; 22(4):223-6. PubMed ID: 2128649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyocin typing of Pseudomonas aeruginosa isolates from children with cystic fibrosis.
    Richardson CJ; Burke V; Bailey M; Fisher A
    Pathology; 1991 Jul; 23(3):229-32. PubMed ID: 1780188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis.
    Pitt TL; MacDougall J; Penketh AR; Cooke EM
    J Med Microbiol; 1986 Mar; 21(2):179-86. PubMed ID: 2419563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies.
    Ojeniyi B; Lam JS; Høiby N; Rosdahl VT
    APMIS; 1989 Jul; 97(7):631-6. PubMed ID: 2502162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas.
    Zierdt CH; Williams RL
    J Clin Microbiol; 1975 Jun; 1(6):521-6. PubMed ID: 809484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization by pyocine typing and serotyping of oral and sputum strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Komiyama K; Habbick BF; Martin T; Tumber SK
    Can J Microbiol; 1987 Mar; 33(3):221-5. PubMed ID: 3105857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Wolz C; Döring G; Lam JS; Rosdahl VT; Høiby N
    APMIS; 1990 May; 98(5):423-31. PubMed ID: 2113398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of polyclonal rabbit antisera with monoclonal antibodies for serological typing of Pseudomonas aeruginosa.
    Strickland MA; Gaston MA; Pitt TL
    J Clin Microbiol; 1988 Apr; 26(4):768-9. PubMed ID: 3130391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.
    Hancock RE; Mutharia LM; Chan L; Darveau RP; Speert DP; Pier GB
    Infect Immun; 1983 Oct; 42(1):170-7. PubMed ID: 6413410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.
    Pier GB; Desjardins D; Aguilar T; Barnard M; Speert DP
    J Clin Microbiol; 1986 Aug; 24(2):189-96. PubMed ID: 2943759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis.
    Thomassen MJ; Demko CA; Doershuk CF; Root JM
    Pediatr Pulmonol; 1985; 1(1):40-5. PubMed ID: 3932947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.
    Speert DP; Farmer SW; Campbell ME; Musser JM; Selander RK; Kuo S
    J Clin Microbiol; 1990 Feb; 28(2):188-94. PubMed ID: 2107198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecology of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Horrevorts AM; Borst J; Puyk RJ; De Ridder R; Dzoljicdanilovic G; Degener JE; Kerrebijn KF; Michel MF
    J Med Microbiol; 1990 Feb; 31(2):119-24. PubMed ID: 2106033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis.
    Burke V; Robinson JO; Richardson CJ; Bundell CS
    Pathology; 1991 Apr; 23(2):145-8. PubMed ID: 1745565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
    Meshulam T; Obedeanu N; Merzbach D; Sobel JD
    Clin Immunol Immunopathol; 1984 Aug; 32(2):151-65. PubMed ID: 6428788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Høiby N; Rosdahl VT
    APMIS; 1991 Jun; 99(6):492-8. PubMed ID: 1905144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyocine typing of mucoid strains of Pseudomonas aeruginosa isolated from children with cystic fibrosis.
    Williams RJ; Govan JR
    J Med Microbiol; 1973 Aug; 6(3):409-12. PubMed ID: 4199274
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients.
    Asboe D; Gant V; Aucken HM; Moore DA; Umasankar S; Bingham JS; Kaufmann ME; Pitt TL
    AIDS; 1998 Oct; 12(14):1771-5. PubMed ID: 9792377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.